Fund Holdings — Caligan Partners LP

Total Portfolio Value
$720.67M
Total Bought
$206.38M
Total Sold
$288.56M
Net Transaction
-$82.18M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX SA(ABVX)1,674,4001,451,924-222,47612,809123,26817.10%+110,459
LIQUIDIA CORPORATION(LQDA)8,118,8928,118,8920101,161184,62425.62%+83,462
MINERALYS THERAPEUTICS INC(MLYS)2,017,3522,772,654+755,30227,295105,13914.59%+77,844
ADMA BIOLOGICS INC02,636,609+2,636,609038,6535.36%+38,653
REVOLUTION MEDICINES INC(RVMD)636,8351,064,249+427,41423,42949,7006.90%+26,271
XENON PHARMACEUTICALS INC(XENE)0444,565+444,565017,8492.48%+17,849
AVALO THERAPEUTICS INC(AVTX)0833,333+833,333010,5921.47%+10,592
AGIOS PHARMACEUTICALS INC(AGIO)1,071,2581,131,205+59,94735,63045,4076.30%+9,777
INHIBRX BIOSCIENCES INC(INBX)0236,383+236,38307,9611.10%+7,961
TYRA BIOSCIENCES INC(TYRA)189,950696,825+506,8751,8189,7491.35%+7,931
VERRICA PHARMACEUTICALS INC(VRCA)0923,910+923,91003,9820.55%+3,982
AURA BIOSCIENCES INC(AURA)200,000227,174+27,1741,2521,4040.19%+152
ANIKA THERAPEUTICS INC1,435,1301,435,130015,18413,4901.87%-1,693
EXELIXIS INC(EXEL)1,525,7301,525,730067,24763,0138.74%-4,234
VERRICA PHARMACEUTICALS INC(VRCA)9,239,1190-9,239,1194,8980—-4,898
EVOLUS INC(EOLS)3,341,9704,138,943+796,97330,78025,4133.53%-5,366
BIOCRYST PHARMACEUTICALS INC(BCRX)638,9080-638,9085,7250—-5,725
REZOLUTE INC(RZLT)1,543,0140-1,543,0146,8820—-6,882
Y-MABS THERAPEUTICS INC2,342,6090-2,342,60910,5650—-10,565
MERUS N V656,999216,954-440,04534,55820,4262.83%-14,132
VERONA PHARMA PLC1,436,8780-1,436,878135,9000—-135,900
Page 1 of 1
Caligan Partners LP — 13F Holdings — Q3 2025 | TickerTrail